Who invested in Acetylon Pharmaceuticals?
Acetylon Pharmaceuticals's investors include Celgene and The Kraft Group.

United States · Growth startup
Funding summaryUpdated 26 Oct 2026
$151Mraised across 6 rounds since 2009, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by masshightech.comSEC filing: $14M sold, first sale Feb 2011
No investor was named in the report.
Reported by masshightech.comSEC filing: $12M sold, first sale Feb 2011
From the SEC filings it signed: 2 on the team.
On the board, as filediBruce A. DowneyElena A. ProkupetsJames A. BradnerKenneth A. Anderson
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Acetylon Pharmaceuticals's investors include Celgene and The Kraft Group.
Acetylon Pharmaceuticals has raised $151M across 6 rounds since 2009.
Acetylon Pharmaceuticals's most recent round was a Growth of $100M in Jul 2013.
Its most recent round, $100M in Jul 2013, is also its largest on record.
Acetylon Pharmaceuticals's first round on record, in Aug 2009, was backed by The Kraft Group.
Acetylon Pharmaceuticals's latest named round is a Growth, in Jul 2013.
Acetylon Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.